Cipla And mAbxience Partner For Essential Biosimilars In South Africa
Partners Will Focus On Oncology And Respiratory-Related Biosimilars
Executive Summary
Cipla has partnered with mAbxience to supply oncology and respiratory-related biosimilars on the WHO model list of essential medicines to South Africa.